Symptoms and the Two Phases of BPAN
At a Glance
BPAN usually has two phases: early childhood developmental delay, severe speech difficulties, and seizures, followed in adolescence or adulthood by worsening movement, thinking, communication, and sleep problems. Seizures may lessen, but sudden changes require urgent medical evaluation.
Understanding the symptoms of Beta-propeller Protein-Associated Neurodegeneration (BPAN) requires looking at the condition over a lifetime. Because BPAN is typically biphasic (meaning it has two distinct stages), the challenges faced today will likely change [1][2]. While every person’s journey is unique and the exact timeline varies, the medical literature provides a roadmap of what to expect during each phase.
Phase 1: Early Childhood (The Neurodevelopmental Phase)
In the first phase, which typically begins in infancy or early childhood, the focus is on developmental milestones and managing epilepsy [3].
- Global Developmental Delay: Most children experience delays in reaching motor milestones like sitting, crawling, and walking [1]. You may also notice hypotonia (low muscle tone or “floppiness”) or spasticity (muscle stiffness) [4].
- Severe Speech Impairment: A hallmark of BPAN is a profound delay in expressive language. Many individuals have little to no spoken language, though they often understand much more than they can say [5][6].
- Epilepsy: Seizures are very common in Phase 1, often appearing around the age of 12 months [7]. These can include focal seizures (starting in one part of the brain) or generalized seizures [8].
- Behavioral Features: Some individuals show “Rett-like” or autistic features, such as repetitive hand movements (stereotypies), hand-wringing, or hand-sucking [9][5]. Hyper-arousal and attention deficits are also frequently reported [10].
The Transition: What Changes?
As the person reaches adolescence or early adulthood, the nature of the condition begins to shift. Interestingly, many families notice that the seizure burden—how often or how severely seizures occur—frequently decreases or even resolves during this time [2][11]. However, this does not mean you should stop or reduce antiseizure medications without your neurologist’s strict guidance. This improvement in epilepsy is usually followed by the onset of new movement challenges.
Phase 2: Adolescence and Adulthood (The Neurodegenerative Phase)
The second phase is characterized by a gradual decline in motor and cognitive skills as iron builds up in the brain [2][12].
- Parkinsonism: This includes rigidity (muscle stiffness), bradykinesia (slowness of movement), and tremors [13]. You might notice “freezing” of gait, where the feet seem stuck to the floor, or a reduced stride length when walking [13][14].
- Dystonia: This involves involuntary muscle contractions that cause twisting or repetitive movements and abnormal postures [2].
- Cognitive Decline: Skills that were previously mastered may become harder to perform, and communication abilities may decrease further [14][12].
- Sleep Disorders: Sleep problems are common throughout life but are often a major concern in Phase 2 [2]. This can include difficulty falling or staying asleep [15].
Knowing When to Seek Urgent Care
Managing BPAN involves distinguishing between the daily challenges of the disease and true medical emergencies. Always follow the specific emergency plan provided by your neurology team.
Medical Emergencies (Seek Immediate Care)
These situations require urgent medical intervention (such as calling 911) to prevent serious complications:
- Status Epilepticus: Any seizure lasting longer than five minutes, or multiple seizures occurring back-to-back without the person waking up in between [16].
- First Aid Reminder: Time the seizure, follow your prescribed rescue-medication plan exactly, protect the person from injury, place them on their side when safe, and never restrain them or put objects in their mouth. Call emergency help for a first, atypical, injured, or breathing-compromising seizure even if it lasts less than five minutes.
- Acute Choking or Respiratory Distress: Active choking, an inability to breathe, blue tint to the lips (cyanosis), or severe struggle to handle secretions.
- Sudden Neurologic Change: While BPAN is progressive, a sudden loss of the ability to move, swallow, or wake up should be evaluated immediately to rule out other causes [2].
Prompt Evaluation (Contact Your Team Soon)
- Aspiration Warning Signs: A new “wet” or gurgly voice after eating, recurrent drooling, or coughing during meals. While not an immediate 911 emergency if breathing is normal, these warrant a prompt clinical swallowing evaluation by a Speech-Language Pathologist [15][2].
Expected Challenges (Not Typically Emergencies)
While these can be stressful, they are often part of the expected course of BPAN and should be discussed at your next scheduled appointment:
- Developmental Plateaus: Periods where there are no apparent gains in new skills [1].
- Brief, Typical Seizures: Seizures that match the usual pattern, end on their own, and are already being managed under an active care plan (though any clustering or change should be reported) [11].
- Gradual Motor Changes: Slightly more stiffness or a slower walking pace developing over several months [14].
- Behavioral Outbursts or Sleep Disturbance: Chronic features that usually require long-term management strategies rather than emergency room visits [10][2].
Common questions in this guide
What are the early signs of BPAN?
What symptoms can appear in the later phase of BPAN?
Can seizures become less frequent in BPAN?
When should a seizure be treated as an emergency?
How can I recognize swallowing problems or aspiration in BPAN?
Which changes in BPAN need urgent medical evaluation?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How can we distinguish between baseline motor challenges and the early signs of Phase 2 parkinsonism?
- 2.Since seizure burden can change over time, when should we revisit our seizure rescue plan or medication dosage?
- 3.What specific signs of 'silent' aspiration or swallowing difficulty should we look for if speaking is difficult?
- 4.Can you help us create a formal, written Emergency Action Plan for prolonged seizures?
- 5.Are current sleep patterns or behavioral challenges typical for BPAN, or should we consider a formal sleep study?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (16)
- 1
Quantitative retrospective natural history modeling of WDR45-related developmental and epileptic encephalopathy - a systematic cross-sectional analysis of 160 published cases.
Saffari A, Schröter J, Garbade SF, et al.
Autophagy 2022; (18(7)):1715-1727 doi:10.1080/15548627.2021.1990671.
PMID: 34818117 - 2
Consensus clinical management guideline for beta-propeller protein-associated neurodegeneration.
Wilson JL, Gregory A, Kurian MA, et al.
Developmental medicine and child neurology 2021; (63(12)):1402-1409 doi:10.1111/dmcn.14980.
PMID: 34347296 - 3
Psychometric outcome measures in beta-propeller protein-associated neurodegeneration (BPAN).
Gavazzi F, Pierce SR, Vithayathil J, et al.
Molecular genetics and metabolism 2022; (137(1-2)):26-32 doi:10.1016/j.ymgme.2022.07.009.
PMID: 35878504 - 4
Phenotypic and Imaging Spectrum Associated With WDR45.
Adang LA, Pizzino A, Malhotra A, et al.
Pediatric neurology 2020; (109()):56-62 doi:10.1016/j.pediatrneurol.2020.03.005.
PMID: 32387008 - 5
Single-center experience with Beta-propeller protein-associated neurodegeneration (BPAN); expanding the phenotypic spectrum.
Chard M, Appendino JP, Bello-Espinosa LE, et al.
Molecular genetics and metabolism reports 2019; (20()):100483 doi:10.1016/j.ymgmr.2019.100483.
PMID: 31293896 - 6
Determination of Health Concepts in β-Propeller Protein-Associated Neurodegeneration.
Kotes E, Gavazzi F, Woidill S, et al.
Journal of child neurology 2025; (40(1)):15-25 doi:10.1177/08830738241283932.
PMID: 39376195 - 7
Severe infantile onset developmental and epileptic encephalopathy caused by mutations in autophagy gene WDR45.
Carvill GL, Liu A, Mandelstam S, et al.
Epilepsia 2018; (59(1)):e5-e13 doi:10.1111/epi.13957.
PMID: 29171013 - 8
Seizure in Neurodegeneration with Brain Iron Accumulation: A Systematic Review.
Emamikhah M, Saiyarsarai P, Schneider SA, et al.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2023; (50(1)):60-71 doi:10.1017/cjn.2021.502.
PMID: 35067244 - 9
WDR45 mutations in Rett (-like) syndrome and developmental delay: Case report and an appraisal of the literature.
Hoffjan S, Ibisler A, Tschentscher A, et al.
Molecular and cellular probes 2016; (30(1)):44-9.
PMID: 26790960 - 10
AAV-Mediated Gene Transfer of WDR45 Corrects Neurological Deficits in the Mouse Model of Beta-Propeller Protein-Associated Neurodegeneration.
Carisi MC, Shamber C, Bishop M, et al.
Human gene therapy 2025; (36(5-6)):637-652 doi:10.1089/hum.2024.224.
PMID: 39978419 - 11
Clinical features and blood iron metabolism markers in children with beta-propeller protein associated neurodegeneration.
Belohlavkova A, Sterbova K, Betzler C, et al.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2020; (28()):81-88 doi:10.1016/j.ejpn.2020.07.010.
PMID: 32811771 - 12
An Autopsy Report of Beta-Propeller Protein-Associated Neurodegeneration with 68-Year Survival, Focusing on Isoform-Specific Distribution of Hyperphosphorylated Tau.
Kai T, Tominaga K, Matsunaga A, et al.
Reports (MDPI) 2026; (9(3)) doi:10.3390/reports9030209.
PMID: 42496506 - 13
Early-Onset Parkinsonism and Halo Sign: Beta-propeller Proteinassociated Neurodegeneration.
Samanta D, Ramakrishnaiah R
Journal of pediatric neurosciences 2020; (15(3)):325-327 doi:10.4103/jpn.JPN_62_20.
PMID: 33531960 - 14
[A woman with beta-propeller protein-associated neurodegeneration identified by the WDR45 mutation presenting as Rett-like syndrome in childhood].
Morisada N, Tsuneishi S, Taguchi K, et al.
No to hattatsu = Brain and development 2016; (48(3)):209-12.
PMID: 27349085 - 15
Childhood Dystonia-Parkinsonism Following Infantile Spasms-Clinical Clue to Diagnosis in Early Beta-Propeller Protein-Associated Neurodegeneration.
Hornemann F, Le Duc D, Roth C, et al.
Neuropediatrics 2020; (51(1)):22-29 doi:10.1055/s-0039-1696688.
PMID: 31505688 - 16
Epileptic spasms: a previously unreported manifestation of WDR45 gene mutation.
Xixis KI, Mikati MA
Epileptic disorders : international epilepsy journal with videotape 2015; (17(4)):467-72 doi:10.1684/epd.2015.0784.
PMID: 26609730
This BPAN symptom information is for educational purposes only and is not medical advice. Follow the individualized plan from your neurology team and seek urgent care for prolonged seizures, breathing problems, or sudden neurologic changes.
Get notified when new evidence is published on Beta-propeller protein-associated neurodegeneration.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.